Veterinary immunology and immunopathology · 2026
The safety evaluation of the pVAX-ROP27 DNA vaccine against Eimeria tenella.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Lv Xiaoling, Li Baojie, Chang Xuan, Zhao Wenrui, Li Menggang, Zhao Jiaqi, Dou Kewei, Niu Zhibin, Bai Rui, Zhang Li, Cui Xiaozhen
Аннотация
DNA vaccines are a promising against avian coccidiosis but they require comprehensive safety evaluation before clinical application. This study assessed the safety and environmental impact of pVAX-ROP27 DNA vaccine against Eimeria tenella in both chickens and mice. Chickens received intramuscular immunizations: single low dose at 1 day (100 μg), repeated doses (100 μg at 7, 14, 21 days), or a high dose (300 μg at 14 days) using three vaccine batches. Mice received a single dose or overdose. Clinical signs, body weight, and histopathology were evaluated. Distribution and persistence of EtROP27 and Kana genes in tissues, faeces, and water were detected by PCR. No adverse reactions or significant weight differences were observed (P > 0.05). Both genes were detected in all tested tissues (heart, liver, spleen, lung, kidney, blood, small intestine, testis, injection site muscle) at 0.5 months but became undetectable by 2 months, suggesting clearance within the detection limit of conventional PCR, with no evidence of genomic integration by this method. No histopathological lesions or environmental gene release (in faeces/water up to 8 weeks) were detected, confirming a favorable safety profile with no detectable tissue damage, integration, or environmental spread within the observation period.